Michail Alevizos MD, Rheumatologist
Fully trained in Rheumatology & former Instructor of Medicine at Columbia University, New York, USA
Diplomate of the American Board of Internal Medicine in Rheumatology
Scientific Director, Department of Rheumatology, Henry Dunant Hospital Center
Ρευματολόγος Αθήνα & Γλυφάδα. Πλήρως ειδικευθείς & Λέκτορας Ιατρικής Columbia University Νέας Υόρκης ΗΠΑ. American Board of Internal Medicine (Rheumatology).
Office location: 10 Grigoriou Lambraki Street, Glyfada - Phone: +30 210 89 80 231
Affiliated institution - Henry Dunant Hospital: 107 Mesogeion Avenue, Athens - Phone: +30 210 69 72 052-054
Dr. Michail Alevizos has been fully trained in Rheumatology at Columbia University of New York, USA.
Education and Training
2008: Graduated from the Medical School of the University of Athens
Passed the United States Medical Licensing Examination (USMLE Step I, II & III) and received ECFMG (Educational Commission of Foreign Medical Graduates) certification
Research Fellow: Molecular Immunopharmacology Laboratory, Tufts University, Boston
Residency: Internal Medicine, Albert Einstein College of Medicine, New York, USA
Fellowship: Rheumatology, Columbia University College of Physicians and Surgeons, New York, USA
Certifications and Licensure
Diplomate of the American Board of Internal Medicine (ABIM) in Internal Medicine and Rheumatology
Licensed to practice medicine in the State of New York, USA
Clinical Experience
Attending Rheumatologist and Instructor of Medicine: Columbia University College of Physicians and Surgeons, New York, USA (2018-2019)
Attending Rheumatologist, Henry Dunant Hospital, Athens, Greece (2020-2026)
Scientific Director, Department of Rheumatology, Henry Dunant Hospital Center (2026-now)
Trained in the use of musculoskeletal ultrasound in clinical practice
Research
First author/researcher on a number of scientific publications in international medical journals
Active member of the American College of Rheumatology (ACR)
Research presented at the ACR Annual Meeting
Current Practice
Private practice: Glyfada, Greece
Affiliated institution: Henry Dunant Hospital, Athens, Greece
Publish date: December 17, 2018
By Bruce Jancin
REPORTING FROM the ACR ANNUAL MEETING
CHICAGO – Patients who meet the criteria for interstitial pneumonia with autoimmune features are more than 14 times more likely to progress to a systemic autoimmune rheumatic disease than are those with idiopathic interstitial lung disease who don’t meet the criteria, Michail Alevizos, MD, reported at the annual meeting of the American College of Rheumatology.
“We think this is a very novel finding. It means that patients with IPAF [interstitial pneumonia with autoimmune features] should be followed and evaluated by rheumatologists over time,” said Dr. Alevizos, who was a rheumatology fellow at Columbia University in New York at the time of the study.
Autoimmune Rheumatic Diseases
These are diseases in which the immune system is overactive and mistakenly attacks healthy organs and tissues of the body itself. The main autoimmune rheumatic diseases are rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus, Sjogren's syndrome, scleroderma, myositis, and vasculitis.
Several of these diseases are more common in women, and it is believed that female hormones, estrogen, are responsible. There are genetic factors that contribute to their development. In addition to genetic factors, there are also environmental risk factors, such as smoking (especially for rheumatoid arthritis).
Rheumatoid Arthritis
Rheumatoid arthritis is a chronic inflammatory disease of the joints and can cause irreversible damage to them. For this reason, early initiation of treatment after diagnosis is important. Smoking is a risk factor that significantly increases the likelihood of someone developing rheumatoid arthritis, especially in individuals with first-degree relatives with the disease. The joints are affected with pain, swelling, and morning stiffness, and the small joints in the hands and feet are most often affected. The goal of treatment is to achieve complete remission of symptoms and inflammation and to prevent damage and loss of joint function. Rheumatologist Athens - Glyfada
Psoriatic Arthritis
It is a chronic inflammatory arthritis that occurs in 30% of people with psoriasis. The picture often resembles rheumatoid arthritis with involvement of many joints and other times it appears as oligoarthritis. Psoriatic arthritis can also affect the spine with low back pain and stiffness. There are now several treatment options available: conventional antirheumatic drugs, biological agents such as TNF inhibitors, IL-17 inhibitors, IL-12/23 inhibitors, IL-23 inhibitors, and JAK inhibitors. In addition to medications, weight loss is recommended for overweight/obese individuals and regular exercise.
Office location: 10 Grigoriou Lambraki Street, Glyfada, 16674 - Phone: +30 210 89 80 231 - Email: alevizos.md@gmail.com
Affiliated institution - Henry Dunant Hospital: 107 Mesogeion Avenue, Athens, 11526 - Phone: +30 210 69 72 052-054 Ρευματολόγος Αθήνα